Surgalign Inc. (SRGA)
Company Description
Surgalign Holdings, Inc., a medical technology company, develops, manufactures, distributes, and markets spine implants worldwide.
It offers products for thoracolumbar procedures, including Streamline TL Spinal Fixation system, a system for degenerative and complex spine procedures; and Streamline MIS Spinal Fixation system, a range of implants and instruments used via a percutaneous or mini-open approach; and interbody fusion devices, as well as products for cervical procedures, such as CervAlign ACP system, a comprehensive anterior cervical plate system; Fortilink-C IBF system, a cervical interbody fusion device that utilizes TETRAfuse 3D technology; and Streamline OCT system, a range of implants used in the occipito-cervico-thoracic posterior spine.
The company also provides motion preservation systems comprising Coflex Interlaminar Stabilization device for the treatment of moderate to severe lumbar spinal stenosis in conjunction with decompression; HPS 2.0 Universal Fixation system, a pedicle screw system used for posterior stabilization of the thoracolumbar spine; and SImmetry SI Joint Fusion system, a minimally invasive surgical implant system to decrease opioid use, pain, and disability.
In addition, it develops Augmented Reality and Artificial Intelligence digital surgery platform to enable digital spine surgery.
The company markets its products through independent spine and biomaterial distributors to hospitals, ambulatory surgery centers, and healthcare providers, as well as through direct sales force.
The company was incorporated in 1997 and is headquartered in Deerfield, Illinois.

Country | United States |
IPO Date | Aug 11, 2000 |
Industry | Medical - Devices |
Sector | Healthcare |
Employees | 217 |
CEO | Terry M. Rich |
Contact Details
Address: 520 Lake Cook Road Deerfield, Illinois United States | |
Website | https://www.surgalign.com |
Stock Details
Ticker Symbol | SRGA |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001760173 |
CUSIP Number | 86882C204 |
ISIN Number | US86882C2044 |
Employer ID | 83-2540607 |
SIC Code | 3842 |
Key Executives
Name | Position |
---|---|
Terry M. Rich | Pres, Chief Executive Officer & Director |
Bob Watkins | Chief Technology Officer |
David B. Lyle | Chief Financial Officer |
Paolo G. Amoruso | Chief Legal Officer, Gen. Counsel & Corporation Sec. |
Suzanne C. Zoumaras | Chief People Officer |
Bryan Cornwall | Executive Vice President of Research and Clinical Affairs |
Christopher Thunander | Vice President & Chief Accounting Officer |
Dr. G. Bryan Cornwall P.Eng., Ph.D. | Executive Vice President of Research and Clinical Affairs |
Enrico Sangiorgio | Executive Vice President of International |
John N. Varela | Executive Vice President of Global Operations |
Marc MacKey | Executive Vice President of Digital Surgery |
Olivier M. Visa | Pres of Global OEM |
William Scott Durall | Chief Commercial Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Feb 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Nov 13, 2023 | 15-12G | Filing |
Oct 02, 2023 | S-8 POS | Filing |
Oct 02, 2023 | S-8 POS | Filing |
Oct 02, 2023 | S-8 POS | Filing |
Oct 02, 2023 | POS AM | Filing |
Oct 02, 2023 | POS AM | Filing |
Oct 02, 2023 | POS AM | Filing |
Sep 29, 2023 | 8-K | Current Report |
Sep 18, 2023 | 4 | Filing |